Measurement of naive CD4 cells reliably predicts potential for immune reconstitution in HIV

Timothy W. Schacker, Ronald J. Bosch, Kara Bennett, Richard B Pollard, Gregory K. Robbins, Ann C. Collier, Roy M. Gulick, John Spritzler, Donna Mildvan

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Background: Pathogenesis studies show that naive CD4 cells are preferentially depleted in lymphoid tissues during HIV infection, and studies of advanced patients suggest levels of naive CD4 cells in blood correlate to total CD4 cells after starting antiretroviral therapy (ARV). We hypothesized that measuring naive CD4 cells in blood in people at earlier stages of disease would identify those at highest risk for poor CD4 reconstitution who may benefit from earlier initiation of ARV. Methods and Findings: We identified 348 patients from multiple AIDS Clinical Trials Group studies who were ARV naive, had a CD4 count between 200 and 500 cells per microliter, a measure of pretreatment-naive CD4 percent, and serial follow-up measures of CD4 count and plasma HIV RNA after starting ARV. We used logistic regression to model the ability of naive CD4 percent to predict 100 and 200 CD4 cell increases after 24 months of therapy. After controlling for baseline viral load and demographic variables, baseline naive but not total CD4 cell count strongly predicted CD4 cell increases. Lower baseline naive CD4 percent was associated with greater time spent at lower CD4 T-cell counts after initiating ARV. Conclusions: Measurement of naive CD4 percent in patients can identify those least likely to reconstitute immunity, who may benefit from earlier ARV treatment.

Original languageEnglish (US)
Pages (from-to)59-62
Number of pages4
JournalJournal of Acquired Immune Deficiency Syndromes
Volume54
Issue number1
DOIs
StatePublished - May 2010

Fingerprint

HIV
CD4 Lymphocyte Count
Therapeutics
Blood Cells
Lymphoid Tissue
Secondary Prevention
Viral Load
HIV Infections
Immunity
Acquired Immunodeficiency Syndrome
Logistic Models
Demography
Clinical Trials
RNA
T-Lymphocytes

Keywords

  • Early therapy
  • Immune reconstitution
  • Naive CD4 T cells

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Cite this

Measurement of naive CD4 cells reliably predicts potential for immune reconstitution in HIV. / Schacker, Timothy W.; Bosch, Ronald J.; Bennett, Kara; Pollard, Richard B; Robbins, Gregory K.; Collier, Ann C.; Gulick, Roy M.; Spritzler, John; Mildvan, Donna.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 54, No. 1, 05.2010, p. 59-62.

Research output: Contribution to journalArticle

Schacker, TW, Bosch, RJ, Bennett, K, Pollard, RB, Robbins, GK, Collier, AC, Gulick, RM, Spritzler, J & Mildvan, D 2010, 'Measurement of naive CD4 cells reliably predicts potential for immune reconstitution in HIV', Journal of Acquired Immune Deficiency Syndromes, vol. 54, no. 1, pp. 59-62. https://doi.org/10.1097/QAI.0b013e3181c96520
Schacker, Timothy W. ; Bosch, Ronald J. ; Bennett, Kara ; Pollard, Richard B ; Robbins, Gregory K. ; Collier, Ann C. ; Gulick, Roy M. ; Spritzler, John ; Mildvan, Donna. / Measurement of naive CD4 cells reliably predicts potential for immune reconstitution in HIV. In: Journal of Acquired Immune Deficiency Syndromes. 2010 ; Vol. 54, No. 1. pp. 59-62.
@article{4933a6f1228f4bcb96ac1d1807f4973d,
title = "Measurement of naive CD4 cells reliably predicts potential for immune reconstitution in HIV",
abstract = "Background: Pathogenesis studies show that naive CD4 cells are preferentially depleted in lymphoid tissues during HIV infection, and studies of advanced patients suggest levels of naive CD4 cells in blood correlate to total CD4 cells after starting antiretroviral therapy (ARV). We hypothesized that measuring naive CD4 cells in blood in people at earlier stages of disease would identify those at highest risk for poor CD4 reconstitution who may benefit from earlier initiation of ARV. Methods and Findings: We identified 348 patients from multiple AIDS Clinical Trials Group studies who were ARV naive, had a CD4 count between 200 and 500 cells per microliter, a measure of pretreatment-naive CD4 percent, and serial follow-up measures of CD4 count and plasma HIV RNA after starting ARV. We used logistic regression to model the ability of naive CD4 percent to predict 100 and 200 CD4 cell increases after 24 months of therapy. After controlling for baseline viral load and demographic variables, baseline naive but not total CD4 cell count strongly predicted CD4 cell increases. Lower baseline naive CD4 percent was associated with greater time spent at lower CD4 T-cell counts after initiating ARV. Conclusions: Measurement of naive CD4 percent in patients can identify those least likely to reconstitute immunity, who may benefit from earlier ARV treatment.",
keywords = "Early therapy, Immune reconstitution, Naive CD4 T cells",
author = "Schacker, {Timothy W.} and Bosch, {Ronald J.} and Kara Bennett and Pollard, {Richard B} and Robbins, {Gregory K.} and Collier, {Ann C.} and Gulick, {Roy M.} and John Spritzler and Donna Mildvan",
year = "2010",
month = "5",
doi = "10.1097/QAI.0b013e3181c96520",
language = "English (US)",
volume = "54",
pages = "59--62",
journal = "Journal of acquired immune deficiency syndromes (1999)",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Measurement of naive CD4 cells reliably predicts potential for immune reconstitution in HIV

AU - Schacker, Timothy W.

AU - Bosch, Ronald J.

AU - Bennett, Kara

AU - Pollard, Richard B

AU - Robbins, Gregory K.

AU - Collier, Ann C.

AU - Gulick, Roy M.

AU - Spritzler, John

AU - Mildvan, Donna

PY - 2010/5

Y1 - 2010/5

N2 - Background: Pathogenesis studies show that naive CD4 cells are preferentially depleted in lymphoid tissues during HIV infection, and studies of advanced patients suggest levels of naive CD4 cells in blood correlate to total CD4 cells after starting antiretroviral therapy (ARV). We hypothesized that measuring naive CD4 cells in blood in people at earlier stages of disease would identify those at highest risk for poor CD4 reconstitution who may benefit from earlier initiation of ARV. Methods and Findings: We identified 348 patients from multiple AIDS Clinical Trials Group studies who were ARV naive, had a CD4 count between 200 and 500 cells per microliter, a measure of pretreatment-naive CD4 percent, and serial follow-up measures of CD4 count and plasma HIV RNA after starting ARV. We used logistic regression to model the ability of naive CD4 percent to predict 100 and 200 CD4 cell increases after 24 months of therapy. After controlling for baseline viral load and demographic variables, baseline naive but not total CD4 cell count strongly predicted CD4 cell increases. Lower baseline naive CD4 percent was associated with greater time spent at lower CD4 T-cell counts after initiating ARV. Conclusions: Measurement of naive CD4 percent in patients can identify those least likely to reconstitute immunity, who may benefit from earlier ARV treatment.

AB - Background: Pathogenesis studies show that naive CD4 cells are preferentially depleted in lymphoid tissues during HIV infection, and studies of advanced patients suggest levels of naive CD4 cells in blood correlate to total CD4 cells after starting antiretroviral therapy (ARV). We hypothesized that measuring naive CD4 cells in blood in people at earlier stages of disease would identify those at highest risk for poor CD4 reconstitution who may benefit from earlier initiation of ARV. Methods and Findings: We identified 348 patients from multiple AIDS Clinical Trials Group studies who were ARV naive, had a CD4 count between 200 and 500 cells per microliter, a measure of pretreatment-naive CD4 percent, and serial follow-up measures of CD4 count and plasma HIV RNA after starting ARV. We used logistic regression to model the ability of naive CD4 percent to predict 100 and 200 CD4 cell increases after 24 months of therapy. After controlling for baseline viral load and demographic variables, baseline naive but not total CD4 cell count strongly predicted CD4 cell increases. Lower baseline naive CD4 percent was associated with greater time spent at lower CD4 T-cell counts after initiating ARV. Conclusions: Measurement of naive CD4 percent in patients can identify those least likely to reconstitute immunity, who may benefit from earlier ARV treatment.

KW - Early therapy

KW - Immune reconstitution

KW - Naive CD4 T cells

UR - http://www.scopus.com/inward/record.url?scp=77951680634&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951680634&partnerID=8YFLogxK

U2 - 10.1097/QAI.0b013e3181c96520

DO - 10.1097/QAI.0b013e3181c96520

M3 - Article

C2 - 20182359

AN - SCOPUS:77951680634

VL - 54

SP - 59

EP - 62

JO - Journal of acquired immune deficiency syndromes (1999)

JF - Journal of acquired immune deficiency syndromes (1999)

SN - 1525-4135

IS - 1

ER -